Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02014337
Title	Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Corcept Therapeutics
Indications	ureter transitional cell carcinoma bladder urothelial carcinoma renal pelvis transitional cell carcinoma peritoneum cancer urethra transitional cell carcinoma breast cancer fallopian tube cancer sarcoma prostate cancer ovarian cancer lung non-small cell carcinoma triple-receptor negative breast cancer
Therapies	Eribulin + Mifepristone
Age Groups:
Covered Countries	USA